gabapentin

Generic: gabapentin

Labeler: preferred pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler preferred pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

gabapentin 800 mg/1

Manufacturer
Preferred Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 68788-8468
Product ID 68788-8468_bbb8f028-c7fc-4d19-af5b-236d122ebb30
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214957
Listing Expiration 2026-12-31
Marketing Start 2023-06-26

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888468
Hyphenated Format 68788-8468

Supplemental Identifiers

RxCUI
310434
UNII
6CW7F3G59X
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA214957 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 800 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (68788-8468-1)
  • 30 TABLET in 1 BOTTLE (68788-8468-3)
  • 60 TABLET in 1 BOTTLE (68788-8468-6)
  • 120 TABLET in 1 BOTTLE (68788-8468-8)
  • 90 TABLET in 1 BOTTLE (68788-8468-9)
source: ndc

Packages (5)

Ingredients (1)

gabapentin (800 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "bbb8f028-c7fc-4d19-af5b-236d122ebb30", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310434"], "spl_set_id": ["180b99a5-7d3d-4ee5-a0cc-1ae0ede646ee"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8468-1)", "package_ndc": "68788-8468-1", "marketing_start_date": "20230626"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (68788-8468-3)", "package_ndc": "68788-8468-3", "marketing_start_date": "20230626"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (68788-8468-6)", "package_ndc": "68788-8468-6", "marketing_start_date": "20230626"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (68788-8468-8)", "package_ndc": "68788-8468-8", "marketing_start_date": "20230626"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (68788-8468-9)", "package_ndc": "68788-8468-9", "marketing_start_date": "20230626"}], "brand_name": "GABAPENTIN", "product_id": "68788-8468_bbb8f028-c7fc-4d19-af5b-236d122ebb30", "dosage_form": "TABLET", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-8468", "generic_name": "Gabapentin", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA214957", "marketing_category": "ANDA", "marketing_start_date": "20230626", "listing_expiration_date": "20261231"}